SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000921895-21-000543
Filing Date
2021-02-23
Accepted
2021-02-23 17:59:25
Documents
1
Period of Report
2021-02-19

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT form412566don_02232021.html 4  
1 OWNERSHIP DOCUMENT form412566don_02232021.xml 4 4579
  Complete submission text file 0000921895-21-000543.txt   6152
Mailing Address ONE BROADWAY 14TH FLOOR CAMBRIDGE MA 02142
Business Address ONE BROADWAY 14TH FLOOR CAMBRIDGE MA 02142 617-514-7149
Summit Therapeutics Inc. (Issuer) CIK: 0001599298 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address ONE BROADWAY 14TH FLOOR CAMBRIDGE MA 02142
Business Address
Donaldson Michael Paul (Reporting) CIK: 0001824022 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36866 | Film No.: 21667159